296 related articles for article (PubMed ID: 37304241)
1. Progress on diagnostic and prognostic markers of pancreatic cancer.
Yang H; Li W; Ren L; Yang Y; Zhang Y; Ge B; Li S; Zheng X; Liu J; Zhang S; DU G; Tang BO; Wang H; Wang J
Oncol Res; 2023; 31(2):83-99. PubMed ID: 37304241
[TBL] [Abstract][Full Text] [Related]
2. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
Yang J; Xu R; Wang C; Qiu J; Ren B; You L
Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845
[TBL] [Abstract][Full Text] [Related]
3. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
[TBL] [Abstract][Full Text] [Related]
4. Investigational biomarkers for pancreatic adenocarcinoma: where do we stand?
Datta J; Vollmer CM
South Med J; 2014 Apr; 107(4):256-63. PubMed ID: 24937521
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.
Smolkova B; Kataki A; Earl J; Ruz-Caracuel I; Cihova M; Urbanova M; Buocikova V; Tamargo S; Rovite V; Niedra H; Schrader J; Kohl Y
Crit Rev Oncol Hematol; 2022 Dec; 180():103865. PubMed ID: 36334880
[TBL] [Abstract][Full Text] [Related]
6. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for pancreatic cancer: recent achievements in proteomics and genomics through classical and multivariate statistical methods.
Marengo E; Robotti E
World J Gastroenterol; 2014 Oct; 20(37):13325-42. PubMed ID: 25309068
[TBL] [Abstract][Full Text] [Related]
8. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
Crawley AS; O'Kennedy RJ
Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
Winter JM; Yeo CJ; Brody JR
J Surg Oncol; 2013 Jan; 107(1):15-22. PubMed ID: 22729569
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers.
Peng J; Madduri S; Clontz AD; Stewart DA
Front Endocrinol (Lausanne); 2023; 14():1106520. PubMed ID: 37181043
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.
Fong ZV; Winter JM
Cancer J; 2012; 18(6):530-8. PubMed ID: 23187839
[TBL] [Abstract][Full Text] [Related]
12. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
13. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.
Makawita S; Dimitromanolakis A; Soosaipillai A; Soleas I; Chan A; Gallinger S; Haun RS; Blasutig IM; Diamandis EP
BMC Cancer; 2013 Sep; 13():404. PubMed ID: 24007603
[TBL] [Abstract][Full Text] [Related]
14. Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.
O'Brien DP; Sandanayake NS; Jenkinson C; Gentry-Maharaj A; Apostolidou S; Fourkala EO; Camuzeaux S; Blyuss O; Gunu R; Dawnay A; Zaikin A; Smith RC; Jacobs IJ; Menon U; Costello E; Pereira SP; Timms JF
Clin Cancer Res; 2015 Feb; 21(3):622-31. PubMed ID: 24938522
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
Asaoka T; Miyamoto A; Maeda S; Tsujie M; Hama N; Yamamoto K; Miyake M; Haraguchi N; Nishikawa K; Hirao M; Ikeda M; Sekimoto M; Nakamori S
Pancreatology; 2016; 16(3):434-40. PubMed ID: 26852169
[TBL] [Abstract][Full Text] [Related]
16. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
[TBL] [Abstract][Full Text] [Related]
17. Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
[TBL] [Abstract][Full Text] [Related]
18. Current and future biomarkers for pancreatic adenocarcinoma.
Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
[TBL] [Abstract][Full Text] [Related]
19. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
20. Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.
Song J; Sokoll LJ; Pasay JJ; Rubin AL; Li H; Bach DM; Chan DW; Zhang Z
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):174-182. PubMed ID: 30333219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
